The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The course of vulvar cancer: The utility of multistate models in the AGO-CaRE-1 study.
 
Christine zu Eulenburg
No Relationships to Disclose
 
Linn Lena Woelber
Travel, Accommodations, Expenses - Medac
 
Klaus H. Baumann
No Relationships to Disclose
 
Petra Neuser
No Relationships to Disclose
 
Falk Thiel
No Relationships to Disclose
 
Alexander Mustea
No Relationships to Disclose
 
Werner Meier
No Relationships to Disclose
 
Philipp Harter
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - AstraZeneca
 
Pauline Wimberger
No Relationships to Disclose
 
Lars Christian Hanker
No Relationships to Disclose
 
Barbara Schmalfeldt
No Relationships to Disclose
 
Ulrich Canzler
No Relationships to Disclose
 
Tanja N. Fehm
Consulting or Advisory Role - Amgen; Novartis; Roche
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; PharmaMar; Roche
Research Funding - Novartis
 
Alexander Luyten
No Relationships to Disclose
 
Martin Hellriegel
No Relationships to Disclose
 
Alexander Reuss
No Relationships to Disclose
 
Anna Suling
No Relationships to Disclose
 
Sven Mahner
Honoraria - AstraZeneca; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro